Logo image of ISO

ISOPLEXIS CORP (ISO) Stock Price, Quote, News and Overview

NASDAQ:ISO - Nasdaq - US4650051067 - Common Stock - Currency: USD

0.7616  +0.02 (+2.78%)

ISO Quote, Performance and Key Statistics

ISOPLEXIS CORP

NASDAQ:ISO (3/20/2023, 8:17:18 PM)

0.7616

+0.02 (+2.78%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week High4
52 Week Low0.6
Market Cap30.21M
Shares39.67M
Float15.32M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO10-08 2021-10-08


ISO short term performance overview.The bars show the price performance of ISO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40 -50

ISO long term performance overview.The bars show the price performance of ISO in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of ISO is 0.7616 USD. In the past month the price decreased by -29.48%. In the past year, price decreased by -79.08%.

ISOPLEXIS CORP / ISO Daily stock chart

ISO Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 24.36 203.70B
DHR DANAHER CORP 28.07 151.18B
A AGILENT TECHNOLOGIES INC 25.59 38.62B
IQV IQVIA HOLDINGS INC 17.15 33.64B
MTD METTLER-TOLEDO INTERNATIONAL 31.26 26.91B
WAT WATERS CORP 31.58 22.26B
ICLR ICON PLC 14.39 16.63B
WST WEST PHARMACEUTICAL SERVICES 31.25 15.27B
ILMN ILLUMINA INC 38.45 14.94B
RVTY REVVITY INC 23.23 13.85B
AVTR AVANTOR INC 17.3 11.78B
TEM TEMPUS AI INC N/A 10.72B

About ISO

Company Profile

ISO logo image IsoPlexis Corp. engages in the development of curative medicines and personalized therapeutics. The company is headquartered in Branford, Connecticut and currently employs 290 full-time employees. The company went IPO on 2021-10-08. The firm is engaged in building solutions to develop curative medicines and personalized therapeutics. The firm's single-cell proteomics systems reveal biological activity in small subsets of cells, allowing researchers to connect directly to in-vivo biology and develop precise and personalized therapies. Its focuses on developing applications of its platform for cancer immunology and cell and gene therapy. The firm's platform is comprised of IsoLight and IsoSpark instruments, IsoCode and CodePlex chip consumables, and IsoSpeak software. Its IsoLight and IsoSpark instruments are designed to be automated benchtop proteomic hubs. Its IsoCode chips use its technology proteomic barcoding to capture single-cell protein information. Its CodePlex chips technology is used to test multiplexed bulk proteins. The Company’s IsoSpeak software provides automated data analysis and accelerated insights with a push-button user interface.

Company Info

ISOPLEXIS CORP

35 Ne Industrial Road

Branford CONNECTICUT US

CEO: Sean Mackay

Employees: 290

Company Website: https://isoplexis.com/

Phone: 12032084111.0

ISOPLEXIS CORP / ISO FAQ

What is the stock price of ISOPLEXIS CORP today?

The current stock price of ISO is 0.7616 USD. The price increased by 2.78% in the last trading session.


What is the ticker symbol for ISOPLEXIS CORP stock?

The exchange symbol of ISOPLEXIS CORP is ISO and it is listed on the Nasdaq exchange.


On which exchange is ISO stock listed?

ISO stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ISOPLEXIS CORP stock?

9 analysts have analysed ISO and the average price target is 1.63 USD. This implies a price increase of 114.29% is expected in the next year compared to the current price of 0.7616. Check the ISOPLEXIS CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ISOPLEXIS CORP worth?

ISOPLEXIS CORP (ISO) has a market capitalization of 30.21M USD. This makes ISO a Nano Cap stock.


How many employees does ISOPLEXIS CORP have?

ISOPLEXIS CORP (ISO) currently has 290 employees.


What are the support and resistance levels for ISOPLEXIS CORP (ISO) stock?

ISOPLEXIS CORP (ISO) has a resistance level at 0.92. Check the full technical report for a detailed analysis of ISO support and resistance levels.


Is ISOPLEXIS CORP (ISO) expected to grow?

The Revenue of ISOPLEXIS CORP (ISO) is expected to grow by 49.37% in the next year. Check the estimates tab for more information on the ISO EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ISOPLEXIS CORP (ISO) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ISOPLEXIS CORP (ISO) stock pay dividends?

ISO does not pay a dividend.


What is the Price/Earnings (PE) ratio of ISOPLEXIS CORP (ISO)?

ISOPLEXIS CORP (ISO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.7).


ISO Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ISO Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ISO. ISO may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ISO Financial Highlights

Over the last trailing twelve months ISO reported a non-GAAP Earnings per Share(EPS) of -2.7. The EPS decreased by -14.08% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity 1.12
Chartmill High Growth Momentum
EPS Q2Q%-27.42%
Sales Q2Q%-39.35%
EPS 1Y (TTM)-14.08%
Revenue 1Y (TTM)-2.88%

ISO Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 47% to ISO. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of 48% and a revenue growth 49.37% for ISO


Ownership
Inst OwnersN/A
Ins Owners0.35%
Short Float %N/A
Short RatioN/A
Analysts
Analysts46.67
Price Target1.63 (114.02%)
EPS Next Y48%
Revenue Next Year49.37%